KLDO
$6.98
Kaleido Biosciences
($.47)
(6.31%)
KLDO
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.59)
Revenue:  $0.00 Mil
Wednesday
Nov 4
7:35 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KLDO reports earnings?
Beat
Meet
Miss

Where is KLDO's stock price going from here?
Up
Flat
Down
Stock chart of KLDO
Analysts
Summary of analysts' recommendations for KLDO
Score
Grade
Pivots
Resistance
$7.98
$7.74
$7.36

$7.12

Support
$6.74
$6.50
$6.12
Tweet
Growth
Description
Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company's product candidates are Microbiome Metabolic Therapies(TM), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. Kaleido Biosciences Inc. is based in Lexington, Massachusetts.